Gilles de la Tourette's Syndrome following Methylphenidate Administration
The DOI matches its Crossref record.
Abstract
SUMMARY: A nine‐year‐old boy with clinically typical ‘minimal brain dysfunction’ developed Tourette's syndrome eight weeks after the start of therapy with methylphenidate. Although methylphenidate was discontinued, the symptoms persisted. Treatment with haloperidol was effective. It is suggested that methylphenidate stimulated an increase in dopamine turnover and brought about the onset of Tourette's syndrome in a vulnerable patient. RÉSUMÉ: Un garçon de neuf ans présentant des signes cliniques typiques de dysfunction cérébrale à minima a debute un syndrome de Tourette, huit semaines après le debut d'un traitement par méthyl‐phénidate. Les symptômes ont persisté malgré l'arrêt de la methylphenidate; un traitement par l'halopéridol a été efficace. Il est possible qu'une augmentation de la circulation de la dopamine stimulée par la méthyl‐phénidate ait déclanché le debut de syndrome de Tourette chez un sujet vulnerable. ZUSAMMENFASSUNG: Ein neun jähriger Junge mit den typischen Zeischen einer ‘minimal brain dysfunction’ entwickelte ein Tourette Syndrom acht Wochen nach dem Beginn einer Therapie mit Methylphenidat. Obgleich das Methylphenidat abgesetzt wurde, blieben die Symptome, bestehen. Zur Behandlung hat sich Haloperidol bewährt. Es wird vermutet, daß eine durch Methylphenidat bedingte Steigerung im Dopamin‐Stoffwechsel den Beginn eines Tourette Syndroms bei einem dafür anfälligen Patienten begünstigt. RESUMEN: Siguiendo la administración de metilfenidato, un niño de 9 años de edad con una ‘disfunción cerebral minima’ clinicamente tipica desarrolló un sindrome de Tourette 8 meses después de empezada una terapeutica con metilfenidato. Aunque el metilfenidato se interrumpió, los sintomas han persistido; el tratamiento con haloperidol es efectivo. Se especula sobre la posibilidad de que un aumento en el recambio de dopamina, estimulado por el metilfenidato, puede desencadenar el inicio del sindrome de Tourette en un paciente vulnerable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
HUNT, R. D., MINDERAA, R. B., & COHEN, D. J. (1985) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60065-0 · Cited by 313
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.009 · Cited by 300
CHAPPELL, P. B., RIDDLE, M. A., SCAHILL, L., LYNCH, K. A., SCHULTZ, R., ARNSTEN, A., LECKMAN, J. F., & COHEN, D. J. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199509000-00010 · Cited by 250
Dopaminergic dysfunction in tourette syndrome
Singer, H. S., Butler, I. J., Tune, L. E., Seifert, W. E., & Coyle, J. T. (1982) · Annals of Neurology · doi:10.1002/ana.410120408 · Cited by 180
Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability?
Borcherding, B. G., Keysor, C. S., Rapoport, J. L., Elia, J., & Amass, J. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90151-t · Cited by 150
Metadata
- Authors
- Golden, G. S.
- Venue
- Developmental Medicine & Child Neurology
- Publisher
- Wiley
- Published
- 1974-02
- Volume
- 16
- Issue
- 1
- Pages
- 76-78
- ISSN
- 0012-1622 (ISSN-L)
- 1469-8749
- OpenAlex
- W2014364710
- Cited by
- 148
- References
- 0
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gilles de la Tourette's Syndrome following Methylphenidate Administration. https://app.cochat.ai/papers/10.1111/j.1469-8749.1974.tb02715.x
- The paper
- Golden, G. S. (1974). Gilles de la Tourette's Syndrome following Methylphenidate Administration. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1974.tb02715.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.